MedTrace Logo

Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery

NCT02901405 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2021-11-26

No results posted yet for this study

Summary

This randomised controlled trial aims to evaluate the difference in surgical site infection following excision of soft tissue sarcomas. The intervention is a negative wound pressure therapy dressing for 120 hours, the control is standard absorbent dressings

Conditions

  • Sarcoma
  • Wound Infection

Interventions

DEVICE

Negative Pressure Wound Therapy (ActivVAC, KCI)

DEVICE

Standard dressings

Current absorbent dressing is 'tegaderm with absorbent pad' (3M)

Sponsors & Collaborators

  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • Sanjay Gupta, MBBS · NHS Greater Glasgow and Clyde

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-18
Primary Completion
2020-04-28
Completion
2020-04-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901405 on ClinicalTrials.gov